Vertigo—the sensation that you or your surroundings are spinning—can be debilitating. For many patients, especially those with a history of migraine, standard treatments fall short. However, a growing body of evidence points to verapamil, a well-known calcium channel blocker, as a promising option for managing vertigo when it is linked to migraine. This article explores how verapamil works, who might benefit, and what the research says about this off-label use.

Understanding the Connection: Migraine and Vertigo

Migraine is much more than a headache. Many individuals experience vestibular symptoms such as dizziness, imbalance, and true vertigo. This syndrome is often called vestibular migraine or migraine-associated vertigo. The underlying mechanism involves abnormal brainstem and cortical excitability, as well as changes in blood flow—areas where calcium channel blockers can exert a stabilizing effect.

How Verapamil Works in Vertigo and Migraine

Verapamil belongs to the class of calcium channel blockers. By inhibiting calcium influx into vascular smooth muscle and cardiac cells, it relaxes blood vessels and reduces vasospasm. For vertigo secondary to migraine, verapamil helps by:

• Stabilizing neuronal excitability in the vestibular nuclei.
• Preventing cortical spreading depression, a key event in migraine aura.
• Improving blood flow regulation to the inner ear and brainstem.
• Reducing the frequency and severity of migraine attacks, which in turn lessens vertigo episodes.

Clinical Evidence for Verapamil in Vertigo

Several clinical studies and case series have examined verapamil for vertigo associated with migraine. A notable 2013 study in the journal Headache found that patients with vestibular migraine who took verapamil experienced a significant reduction in both headache days and vertigo attacks. Another review highlighted that calcium channel blockers like verapamil are particularly effective when other prophylactic medications have failed. While not FDA-approved specifically for vertigo, verapamil is widely prescribed off-label by neurologists and otologists for this purpose.

Dosage and Considerations

Verapamil is typically started at a low dose (e.g., 80 mg twice daily) and slowly titrated upward under medical supervision. Common side effects include constipation, low blood pressure, and mild fatigue. Because verapamil can affect heart conduction, baseline ECG is recommended. It is important to note that calcium channel blockers are generally well-tolerated, and many patients report sustained improvement in vertigo symptoms within 4–8 weeks.

Who Should Consider Verapamil?

Ideal candidates for verapamil therapy include:

• Patients with confirmed vestibular migraine who experience recurrent vertigo.
• Individuals who have not responded to lifestyle changes, dietary modifications, or first-line migraine preventives.
• Those who also have hypertension or certain arrhythmias, as verapamil can address both conditions.

Conclusion: A Valuable Tool in the Vertigo Toolkit

For patients suffering from vertigo that is driven by migraine, verapamil offers a scientifically grounded and clinically proven option. As a member of the calcium channel blockers family, it targets the vascular and neurological roots of the problem. While not a first-line treatment for all types of dizziness, it should be considered whenever migraine is a contributing factor. Always consult with a healthcare provider before starting or adjusting any medication.